ENTITY
Seagen

Seagen (SGEN US)

40
Analysis
Health CareUnited States
Seagen Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases, as well as offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seagen serves customers worldwide.
more
07 Oct 2015 11:15

Morningstar Healthcare Observer: Biotech Industry Undervalued

The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...

Logo
292 Views
Share
06 Oct 2015 11:03

SoulCycle IPO - Good for your portfolio and your soul?

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...

Logo
255 Views
Share
03 Mar 2015 11:02

End-2015 should see Euro-zone EQ up +40-60%, Nikkei over 22K, USDCHF over 1.02, USDJPY over 125

Another blow-up non-farm number coming up? Run US macro bears, run!   European equities will end up 30% to 60% for the year. Play through...

Share
02 Feb 2015 14:48

The Matrix: A Strategist's roving thoughts: Swiss Francs, Europe, Alibaba

Key Call: STILL people are not catching up and/or doing the work on KVP’s high conviction long DollarSwissy call, I know, I know, it’s downright...

Share
bullishMacroeconomics
20 Jan 2015 22:51

The IMF's Patience with the ECB Wears Thin

The updated World Economic Outlook reveals that the IMF is (rightly) fed up with the ECB’s timid approach to monetary policy.  Monetary policy in...

Logo
262 Views
Share
x